Following a WHO alert on 66 child deaths in Gambia, India investigates four cough syrups.

1 Min Read

The World Health Organization (WHO) issued a warning that four cough syrups produced by a pharmaceutical company in Haryana may have contributed to the deaths of 66 children in The Gambia, prompting the government to launch an investigation. 

Top Ministry of Health and Family Welfare sources claim that on September 29, the WHO informed the Drugs Controller General of India (DCGI) about the cough syrups. According to the sources, the Central Drugs Standard Control Organization promptly brought the issue up with the Haryana regulatory body and started a thorough inquiry.

According to the sources, M/s Maiden Pharmaceutical Limited produces the cough syrups in Sonepat, Haryana. They continued by saying that based on the evidence at hand, it appears the company has solely exported these goods to The Gambia. The business has not yet responded to the accusations. This morning, the company’s administrative office in Pitampura, Delhi, was discovered to be closed.

Share This Article
Leave a comment

Leave a Reply